GLP-1s on Formulary Tiers: What Tier Placement Means for Your Copay

GLP-1 Prescriptions Editorial Team · July 17, 2026 · 8 min read
Affiliate Disclosure: This site contains affiliate links to telehealth providers. If you click a link and make a purchase, we may receive a commission at no extra cost to you. All opinions are our own. Links marked "Paid link" are sponsored placements. See our full disclosure.

Formulary Tiers Explained

Your insurance plan's formulary organizes medications into tiers, each with different cost-sharing. For GLP-1 medications, your tier placement determines whether you pay $25 or $250 per fill — or whether the medication is covered at all.

Tier 1 (Generic): Lowest copay ($5-15). No GLP-1 is currently available as a generic, so this tier doesn't apply yet. When semaglutide's patent expires and generics enter the market, this will change.

Tier 2 (Preferred Brand): Moderate copay ($25-50). Some plans place one GLP-1 here as the "preferred" option. If your plan prefers Wegovy over Zepbound (or vice versa), the preferred option gets Tier 2 placement.

Tier 3 (Non-Preferred Brand): Higher copay ($50-100). The non-preferred GLP-1 typically lands here. You can still get it, but you'll pay more.

Tier 4/Specialty: Highest cost-sharing ($100-250+ or percentage coinsurance). Many plans place GLP-1s on the specialty tier due to their high list price. Specialty tier cost-sharing is often 25-33% of the drug's cost rather than a flat copay.

How to Check Your Plan's Tier Placement

Three ways to find your GLP-1's formulary tier: check your plan's formulary online (search by drug name), call your insurer's member services, or ask your pharmacist to run a test claim. The test claim is the most accurate method because it reflects your specific plan's adjudication rather than a generic formulary list.

When checking, look up both semaglutide and tirzepatide. If one is on a better tier than the other, that affects your prescriber's recommendation and your out-of-pocket cost.

Brand-Name Rx

Sesame Care

Brand-Name Marketplace

From $99/visit

FDA-approved brand-name medications only (Wegovy, Zepbound, Foundayo). Not compounded.

Check Eligibility →

Requesting a Tier Exception

If your GLP-1 is on a high tier but a lower-tier option isn't clinically appropriate (you've tried it and had adverse effects, or it's medically contraindicated), your prescriber can request a tier exception. This moves the medication to a lower cost-sharing level.

Tier exception requests require clinical documentation: why the preferred/lower-tier option is inappropriate for you specifically. Common justifications include documented adverse effects on the lower-tier medication, medical contraindications, or documented treatment failure on the alternative.

Specialty Tier and Copay Accumulators

A growing concern for GLP-1 patients on specialty tiers: copay accumulator programs. These programs prevent manufacturer copay cards from counting toward your deductible or out-of-pocket maximum. If your plan uses a copay accumulator, the manufacturer savings card reduces your immediate cost but doesn't help you reach your deductible — meaning you'll face high costs again once the savings card runs out.

Check with your plan whether they use a copay accumulator (also called "copay maximizer"). If they do, factor this into your annual cost calculation. Some states have passed laws restricting copay accumulators, but the landscape varies.

Editor's Choice

Embody

Top Pick — $400 CPA

From $249/mo

Injectable semaglutide only. Compounded — not FDA-approved.

Check Eligibility →
$100 Off

Found Health

$100 Off Promo

From $129/mo

Compounded — not FDA-approved.

Check Eligibility →
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. GLP-1 receptor agonists are prescription medications with potential side effects including nausea, vomiting, diarrhea, and in rare cases, pancreatitis or thyroid tumors. Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Always consult a licensed healthcare provider before starting any medication. Compounded medications are not FDA-approved for safety, efficacy, or quality.